Can circulating biomarkers identify heart failure patients at low risk?

被引：4
|
作者：
Richards, A. Mark [1 ,2 ]
Frampton, Chris M. [1 ]
机构：
[1] Univ Otago, Christchurch Heart Inst, Christchurch 8014, New Zealand
[2] Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷 / 12期
关键词：
PRESERVED EJECTION FRACTION; EMERGENCY-DEPARTMENT; DIAGNOSTIC PROTOCOL; SERUM GALECTIN-3; CHEST-PAIN; TRIAL; HOSPITALIZATION;
D O I：
10.1002/ejhf.438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1213 / 1215
页数：3
相关论文
共 50 条
  • [1] Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients
    O'Connell, Thomas M.
    Logsdon, David L.
    Mitscher, Gloria
    Payne, R. Mark
    METABOLOMICS, 2021, 17 (10)
  • [2] Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients
    Thomas M. O’Connell
    David L. Logsdon
    Gloria Mitscher
    R. Mark Payne
    Metabolomics, 2021, 17
  • [3] Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
    Collier, Patrick
    Watson, Chris J.
    Voon, Victor
    Phelan, Dermot
    Jan, Aftab
    Mak, George
    Martos, Ramon
    Baugh, John A.
    Ledwidge, Mark T.
    McDonald, Kenneth M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (10) : 1087 - 1095
  • [4] A prediction rule to identify low-risk patients with heart failure
    Auble, TE
    Hsieh, M
    Gardner, W
    Cooper, GF
    Stone, RA
    McCausland, JB
    Yealy, DM
    ACADEMIC EMERGENCY MEDICINE, 2005, 12 (06) : 514 - 521
  • [5] Circulating Biomarkers in Heart Failure
    Berezin, Alexander E.
    HEART FAILURE: FROM RESEARCH TO CLINICAL PRACTICE, VOL 3, 2018, 1067 : 89 - 108
  • [6] Circulating biomarkers in patients with heart failure and preserved ejection fraction
    O'Meara E.
    De Denus S.
    Rouleau J.-L.
    Desai A.
    Current Heart Failure Reports, 2013, 10 (4) : 350 - 358
  • [7] Low circulating androgens and mortality risk in heart failure
    Gueder, G.
    Frantz, S.
    Bauersachs, J.
    Allolio, B.
    Ertl, G.
    Angermann, C. E.
    Stoerk, S.
    HEART, 2010, 96 (07) : 504 - 509
  • [8] A Targeted Proteomic Approach to Identify Circulating Biomarkers of Heart Failure Risk in Patients With Type 2 Diabetes Mellitus in DECLARE-TIMI 58
    Berg, David
    Wiviott, Stephen D.
    Raz, Itamar
    Kamanu, Frederick
    Im, KyungAh
    Cahn, Avivit
    Mosenzon, Ofri
    Bhatt, Deepak L.
    Jarolim, Petr
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John
    Huo, Yong
    Lopez-Sendon, Jose L.
    Ardissino, Diego
    Gause-Nilsson, Ingrid A.
    Sabatine, Marc S.
    Morrow, David A.
    CIRCULATION, 2020, 142
  • [9] Multiple Kidney Biomarkers Can Risk-Stratify Chronic Heart Failure Patients
    Kadowaki, Shinpei
    Shishido, Tetsuro
    Narumi, Taro
    Otaki, Yoichiro
    Honda, Shintaro
    Hasegawa, Hiromasa
    Funayama, Akira
    Arimoto, Takanori
    Takahashi, Hiroki
    Miyamoto, Takuya
    Watanabe, Tetsu
    Kubota, Isao
    CIRCULATION, 2012, 126 (21)
  • [10] Testing for Frailty: Can We Identify a High Risk Population in Patients with Advanced Heart Failure?
    Fida, Nadia
    Patel, Snehal R.
    Gentile, Kevin
    Abreu, Yokasta
    Negassa, Abdissa
    Verghese, Joe
    Maybaum, Simon
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S83 - S83
12345